E
Medicenna Therapeutics Corp. MDNA.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -72.86% -128.92% -198.13% -147.31% -56.08%
Total Depreciation and Amortization 807.14% 371.43% 61.11% -3.45% -67.06%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1,332.04% 340.17% 255.25% 266.38% 85.47%
Change in Net Operating Assets -119.06% -112.15% 13.32% -70.05% 13.93%
Cash from Operations -17.64% -25.03% -8.05% -26.01% 0.05%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- 16,005.15% -12.86% -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 12,377.81% 40,072.41% -16.25% -- -100.73%
Foreign Exchange rate Adjustments 310.54% 98.06% -30.63% -135.36% -148.43%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 155.88% 131.84% -47.79% -221.12% -208.79%
Weiss Ratings